https://www.selleckchem.com/pr....oducts/ll37-human.ht
In this review article we aim to describe sex-related differences in HF and how these differences might explain why women with HF can expect to survive longer than men.The tricuspid valve has been neglected for a long time and severe tricuspid regurgitation (TR) was largely undertreated in the past due to a high operative risk. In the last years we observed the development of different less invasive percutaneous options to treat TR. Currently, percutaneous treatments are reserved for high-risk patients presenting with advanced stage